Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05471921 · ClinicalTrials.gov registry record · NA
Effectiveness of an Evidence-based Stepped Care System for Alcohol and Other Drug Use Problems Among Congolese Refugees in Zambia
A NA study of Alcohol and Substance-Related Mental Disorders, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 2
- Study locations
NCT05471921: Completed NA study of Alcohol and Substance-Related Mental Disorders, sponsored by Columbia University.
NCT05471921 is a NA study of Alcohol and Substance-Related Mental Disorders that has completed, run by Columbia University. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05471921, a NA study of Alcohol and Substance-Related Mental Disorders, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a randomized controlled trial (RCT) evaluating the effectiveness of a screening, brief intervention, and referral to treatment (SBIRT) stepped-care system in reducing unhealthy AOD use among Congolese refugees and the host community in Mantapala, an integrated settlement in northern Zambia.
Primary Outcome
AUDIT is a 10-item measure of hazardous alcohol use with a possible range of 0-40 (total scale score). Higher scores are associated with more hazardous use.
Conditions Studied
Interventions
- BEHAVIORAL Treatment as usual
- BEHAVIORAL SBIRT
Study Locations (2)
New York
- Columbia University - New York
Luapula Province
- Mantapala Refugee Settlement - Nchelenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-04-26 |
| Est. Completion | 2025-02-24 |
| Phase | NA |
What the finished NCT05471921 record still lists
NCT05471921 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Alcohol and Substance-Related Mental Disorders appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual is the first listed.
NCT05471921 reports a single indexed study location in New York, Luapula Province.
Frequently Asked Questions
What is clinical trial NCT05471921 about?
NCT05471921 is a clinical study titled "Effectiveness of an Evidence-based Stepped Care System for Alcohol and Other Drug Use Problems Among Congolese Refugees in Zambia". This is a randomized controlled trial (RCT) evaluating the effectiveness of a screening, brief intervention, and referral to treatment (SBIRT) stepped-care system in reducing unhealthy AOD use among Congolese refugees and the host community in Mantapala, an integrated settlement in northern Zambia.
What is the current status of trial NCT05471921?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2023-04-26. Estimated completion is 2025-02-24.
What conditions does trial NCT05471921 study?
This clinical trial studies the following conditions: Alcohol and Substance-Related Mental Disorders.
What interventions are being tested in trial NCT05471921?
The interventions under investigation include: Treatment as usual (BEHAVIORAL), SBIRT (BEHAVIORAL).
Who is sponsoring clinical trial NCT05471921?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05471921 being conducted?
This trial has 2 study locations across New York, Luapula Province. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05471921's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI